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ABSTRACT
Introduction Despite progress towards the Joint United 
Nations Programme on HIV/AIDS 95-95-95 targets, 
South Africa is still suffering from one of the largest HIV 
epidemics globally. In this study, we generated high- 
resolution HIV prevalence maps and identified people living 
with HIV (PLHIV) in underserved areas to provide essential 
information for the optimal allocation of HIV- related 
services.
Methods The data come from the South Africa 
Demographic and Health Survey conducted in 2016 
and spatial variables from other published literature. We 
produced high- resolution maps of HIV prevalence and 
underserved areas, defined as a greater than 30 min travel 
time to the nearest healthcare facility. Using these maps 
and the population density, we mapped PLHIV and the 
PLHIV within underserved areas for 30, 60 and 120 min 
thresholds.
Results There was substantial geographic variation in HIV 
prevalence, ranging from 1.4% to 24.2%, with a median of 
11.5% for men, and from 2.1% to 48.1%, with a median of 
20.6% for women. Gauteng province showed the highest 
density for both HIV prevalence and PLHIV. 80% of all areas 
in the country were identified as underserved areas (30 
min threshold), which contained more than 16% and 20% 
of the total men and women living with HIV, respectively. 
KwaZulu- Natal province had the largest number of PLHIV 
in underserved areas (30 min threshold) and showed less 
than one healthcare facility per 1000 PLHIV.
Conclusion Our study showed extensive spatial variation 
of HIV prevalence and significant numbers of PLHIV in 
underserved areas in South Africa. Moreover, we identified 
locations where HIV- related services need to be intensified 
to reach the ~1.5 million PLHIV in underserved areas, 
particularly in KwaZulu- Natal province, with less than one 
healthcare facility per 1000 PLHIV.
INTRODUCTION
With the rapid achievement of the 90-90-90 
strategy (90% of all people living with 
HIV (PLHIV) know their HIV status, 90% 
of all people diagnosed with HIV receive 
sustained antiretroviral therapy (ART) 
and 90% of all people receiving ART have 
viral suppression) to guide country- led and 
regional- led efforts to rapidly scale up HIV 
prevention and treatment services, the 
annual global number of new HIV infec-
tions had declined from 2.1 million in 2010 
Key questions
What is already known?
 ► South Africa suffers from one of the largest HIV epi-
demics, with more than 7.5 million people living with 
HIV (PLHIV) in 2018.
 ► The country achieved its first 90-90-90 target by diag-
nosing more than 90% of PLHIV.
 ► However, the other targets (the proportion of diag-
nosed people on antiretroviral therapy (ART) and the 
proportion of virally suppressed PLHIV on ART) are 
still behind, despite the aggressive expansion of ART 
coverage.
What are the new findings?
 ► South Africa showed extensive spatial variation of HIV- 
positive population for both genders.
 ► The largest PLHIV population is concentrated in the 
Gauteng province, with a density of 13 862 women per 
5 km2 and 15 484 men per 5 km2.
 ► More than 80% of areas in the country are more than 
30 min travel time from the nearest healthcare service.
 ► More than 16% of men living with HIV and 20% of 
women living with HIV reside in underserved ar-
eas where the nearest healthcare service cannot be 
reached within 30 min travel time.
 ► A total of 80% of PLHIV reside in only five provinces; 
KwaZulu- Natal province has the largest number of 
PLHIV within 30 min threshold of underserved areas 
containing more than 100 000 of PLHIV for each gen-
der (149 197 for men and 174 543 for women) and 
shows less than one healthcare facility per 1000 PLHIV.
What do the new findings imply?
 ► There are still several barriers for HIV treatment ser-
vice coverage that need to be overcome, particularly 
for PLHIV living in underserved areas where health 
services are not likely to be reached within threshold 
times.
 ► Efforts to allocate resources for HIV treatment need to 
be oriented towards the PLHIV located in underserved 
areas in provinces with low number of healthcare fa-
cilities per 1000 PLHIV.
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to 1.7 million (16%) by 2018.1 This progress led to 
revised 95-95-95 targets and an acceleration of efforts 
to end the HIV/AIDS epidemic by 2030. In addi-
tion, the Joint United Nations Programme on HIV/
AIDS (UNAIDS) announced the Fast- Track approach 
focusing on the 30 countries that account for most 
of the world’s people newly infected with HIV, which 
includes South Africa.2
South Africa, with more than 7.5 million PLHIV,1 
has one of the largest HIV epidemics in the world. 
To reverse the tide of the epidemic, the country3 
aggressively scaled up ART coverage, which has led to 
improvements in HIV outcomes. In 2018, the annual 
number of new HIV infections declined to 240 000 
people, which represented 0.49% of the uninfected 
population, compared with 0.64% in 2015.1 South 
Africa has achieved a 90% of PLHIV diagnosed, 68% 
of those diagnosed on ART and 88% of those on ART 
virally suppressed in 2018,4 5 and is potentially on its 
way to meeting the 90-90-90 targets by 2022.6 Despite 
remarkable progress, HIV prevalence in the country 
remains persistently high with 18.9% of adults aged 
15 and older infected with the virus, and more 
than 200 000 new infections occurring every year.7 8 
Although the proportion of PLHIV who know their 
HIV status has been steadily increasing, the propor-
tion of PLHIV on ART is remarkably low despite the 
expansion of ART coverage. The likelihood of South 
Africa achieving its 95-95-95 targets and ending the 
HIV epidemic by 2030 remains far from certain.
In order to meet those targets, we have previously 
argued for prioritising resource allocation and accel-
erating HIV prevention and treatment services in 
certain high- risk areas in South Africa.9 10 South Africa 
shows substantial spatial variation in the HIV epidemic 
with infections clustering in the eastern part of the 
country, between the Limpopo and KwaZulu- Natal prov-
inces.6 11 However, most past measures of HIV prevalence 
in the country are frequently available only for large 
geographical administrative units (ie, low spatial resolu-
tion), or they are only focused on localised epidemics.7 
These large- scale national or regional measures can 
obscure localised aspects of the HIV transmission process 
across the country. Moreover, these measures are esti-
mated for the total population, but spatial disparities of 
the epidemic and their social and behavioural drivers 
can exist.8 Microlevel analyses on the spatial structure 
of the HIV epidemic and the density of PLHIV in low- 
access areas could help facilitate the operation of HIV 
prevention and treatment services by targeting resource 
allocations to the areas. To maximise the achievement of 
the 95-95-95 targets by 2030, identifying areas where the 
burden of HIV is concentrated could play a key role in 
recognising vulnerable populations at high risk of infec-
tion, but also in prioritising the access to critical health-
care for PLHIV in these areas.12–19
Given this context, the main objective of this study was 
to generate high- resolution, spatial predictions of HIV 
epidemiological measures for men and women (HIV 
prevalence and density of PLHIV) in South Africa. We 
then used these spatial predictions to conduct a detailed 
spatial analysis of underserved areas from critical health-
care services to identify men and women living with HIV 
in areas with low access to HIV prevention and treatment 
services. This information would be of high relevance 
for assisting the national strategy to target appropriate 
areas and populations and achieve the UNAIDS targets 
in South Africa.20
METHODS
Study area and data sources
The main source of data for this study was the South Africa 
Demographic and Health Survey (SADHS) conducted in 
2016,21 which contains HIV serological biomarker infor-
mation along with the corresponding spatial information 
of sample locations. The SADHS is a cross- sectional house-
hold survey designed to collect nationally representative 
Figure 1 Sample locations. (A) Demographic and Health Survey sample locations for South Africa Demographic and Health 
Survey (SADHS) in 2016, and (B) healthcare facility locations. Map was created using ArcGIS by ESRI V.10.5 (http://www.esri.
com).
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data on population, health and socioeconomic parame-
ters.21 Individuals were enrolled in the SADHS via two- 
stage sampling procedure to select households. Men 
and women aged 15–49 in the selected households were 
eligible for the study. Of 12 132 participants (3618 men 
and 8514 women), 4862 individuals (2136 men and 2726 
women) who interviewed and provided specimens for 
HIV testing were included. The SADHS sample locations 
are where the individuals participated the survey. The 
number of the sample location is 601 for men and 633 
for women. The global positioning system was used to 
identify and record the geographical coordinates of each 
SADHS sample location (figure 1A).22 Further details 
related to the population of the study can be found in 
the online supplemental materials.
Demographic and Health Surveys (DHS) has 
conducted nationally representative anonymous HIV 
testing to track HIV epidemics by collecting blood from 
representative samples of the population of women and 
men in a country since 2001.21 23 Respondents who partic-
ipated in the testing received educational materials and 
referrals for free voluntary counselling and testing. HIV 
serostatus was determined using the ELISA, based on a 
parallel testing algorithm. Further details related to the 
SADHS methodology, study design and data can be found 
in online supplemental materials and elsewhere.21 23 This 
study follows the guidelines of the Strengthening the 
Reporting of Observational Studies in Epidemiology.24
Selection of spatial variables and HIV mapping
We selected variables from the SADHS data sets and other 
sources to investigate the association between socioeco-
nomic and behavioural factors and the spatial structure 
of HIV in South Africa. Six socioeconomic and behav-
ioural variables that have been previously associated 
with the risk of HIV prevalence were measured for men 
and five for women.12 25 These included education level, 
poverty estimated using the DHS wealth index, condom 
use, number of lifetime sexual partners, if the partici-
pants had ever been previously tested for HIV and male 
circumcision (MC; male only). MC was a self- reported 
variable of circumcision status and thus did not consider 
which types of circumcision (eg, voluntary medical MC 
or traditional MC) were conducted. These variables were 
evaluated as percentages at each SADHS sample location.
We included seven environmental variables in the anal-
ysis: the normalised difference vegetation index (NDVI), 
night light, distance to main roads and dams, global 
human influence index (GH- I), friction map repre-
senting allocated fastest speed of travel based on the 
types of travel mode estimated within the pixel and popu-
lation density. We quantified all variables at each DHS 
sample location. For example, we extracted the NDVI 
value at each SADHS sample location, and the distance 
from each sample to the closest main road was calculated 
and assigned at each sample location. The definition and 
descriptive statistics for each variable are presented in 
online supplemental table S1.
To generate disease maps of HIV prevalence in South 
Africa for each gender, we implemented a method previ-
ously developed to describe the spatial structure of HIV 
prevalence in several countries in sub- Saharan Africa 
(SSA) including Kenya, Malawi, Mozambique, Tanzania 
and Zimbabwe.12 25 We used ordinary kriging mapping 
methods to generate continuous surface maps for each 
Table 1 Variables in the final logistic regression models for men and women
Gender Variable Estimate SE P value
Moran’s 
Index P value
Women Intercept −1.008441 0.1343 <0.001 – –
Condom use 0.007380 0.0015 <0.001 0.04 0.08
Poverty 0.005842 0.0012 <0.001 0.19 <0.001
Lifetime number of sexual partners (<3) −0.009180 0.0016 <0.001 0.07 0.00
Friction −24.314521 11.6500 0.04 – –
Distance to main road −0.004377 0.0031 0.16 – –
NDVI 0.892539 0.1972 <0.001 – –
Men Intercept −2.376504 0.3426 <0.001 – –
Ever been tested for HIV 0.006193 0.0028 0.03 0.04 0.06
Poverty 0.007057 0.0019 <0.001 0.21 <0.001
Lifetime number of sexual partners (<3) −0.014912 0.0031 <0.001 0.04 0.07
Male circumcision −0.009507 0.0020 <0.001 0.11 <0.001
GH- I 0.018049 0.0059 <0.001 – –
Distance to main road −0.004983 0.0047 0.29 – –
NDVI 0.230944 0.2767 0.40 – –
Bold values denote statistical significance at the p <0.05 level.
GH- I, global human influence index; NDVI, normalised difference vegetation index.
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significant socioeconomic, demographic and behavioural 
factor identified in the multivariable regression model. 
The variables satisfied both criteria: (1) the bivariate 
logistic regression slope coefficient must have p value 
<0.1; and (2) the significance test for spatial autocorrela-
tion must have p value <0.1. Then, we generated a map 
of HIV prevalence in raster format with 5 km grid reso-
lution by substituting values from all continuous surface 
maps into the gender- specific multivariable logistic 
regression model for each gender. Finally, a 5 km × 5 km 
pixel resolution map of the density of women and men 
living with HIV was generated by combining the HIV 
prevalence map with the women and men density maps. 
Further details related to this methodology can be found 
in online supplemental materials.
Mapping HIV-underserved areas
To identify HIV- underserved areas, we used two data 
sets: the friction map from Malaria Atlas Project and the 
locations of public healthcare facilities in South Africa 
(figure 1B).26 We employed travel time estimates, which 
offer the most accurate representation of the cost of 
travel, for measuring geographic accessibility and for 
identifying underserved areas.27 28 We obtained all public 
healthcare facilities and private- not- for- profit sectors 
managed by government (eg, the Ministry of Health), 
local authorities, and faith- based organisation and non- 
governmental organisation to represent public health 
services.26 A total of 4287 healthcare facilities were 
included in the analysis. We modelled travel time as a 
function of distance and travel speed. It can be conceptu-
alised as the cost of movement using the cell dimensions 
(pixel resolution) and travel time assigned to each cell. 
In this model, travel occurs through cell to cell in both 
cardinal and diagonal directions, and a travel time was 
designated for each cell, representing the time required 
to traverse the cell estimated from the friction map. To 
identify underserved areas, we reclassified the accumu-
lated travel time surface into a Boolean surface based 
on whether the cell was greater than three thresholds, 
30, 60 and 120 min, from a healthcare location, then 
we converted the underserved areas from a raster grid 
to a vector data form (polygons) to identify the women 
Figure 2 High- resolution maps of HIV prevalence and people living with HIV (PLHIV) in South Africa. High- resolution maps of 
HIV prevalence in South Africa for (A) men and (B) women in 2016; geographic dispersion of men (C) and women (D) living with 
HIV in South Africa. HIV prevalence for women is higher in the north- eastern part of the country from Limpopo to Eastern Cape 
province, whereas HIV prevalence for men is more concentrated in the mid- eastern part of the country among the Gauteng 
and KwaZulu- Natal provinces. The density of PLHIV for both genders shows similar spatial patterns, concentrating in Gauteng 
province. Maps were created using ArcGIS by ESRI V.10.5 (http://www.esri.com).
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and men living with HIV in these areas. We used three 
travel times, that is, 30, 60 and 120 min, as thresholds for 
underserved areas in this study based on previous studies. 
Various travel times have been suggested as a threshold 
to access healthcare in South Africa and other countries 
in SSA.15 29–31 A study of PLHIV in Uganda reports 30 min 
as a median travel time for PLHIV to access healthcare 
facility.29 Another study for travel time to access primary 
healthcare in South Africa shows 81 min as a median 
travel time, and 65% of households travel more than 60 
min to attend the primary healthcare.15 In addition, other 
studies in African countries use 120 min as a threshold 
to access healthcare facilities.30 31 Finally, we generated 
density maps of women living with HIV and men living 
with HIV in the underserved areas using the continuous 
surface maps of HIV generated in the previous step and 
the estimations for underserved areas. Further details 
related to this methodology, study design and data can 
be found in online supplemental materials.
Patient and public involvement
There were no patients involved in this research.
RESULTS
Spatial variable selection
The variables selected for inclusion in the final logistic 
regression models for men and women are summa-
rised in table 1, and the results from bivariate logistic 
regression analysis and the corresponding spatial corre-
lation analysis (Moran’s Index) for each variable are 
presented in online supplemental table S2. For men, the 
final logistic model included ever been tested for HIV, 
poverty, lifetime number of sexual partners, MC, GH- I, 
distance to main roads and NDVI. For women, the final 
logistic model included condom use, lifetime number 
of sexual partners, friction, distance to main roads and 
NDVI. Continuous surface maps of each variable selected 
for men (online supplemental figure S1) and women 
(online supplemental figure S2) are included in online 
supplemental materials.
HIV disease mapping
Figure 2A,B illustrates the spatial distribution of HIV 
prevalence estimated using the final multivariable logistic 
regression models for men and women, respectively. 
These maps show the distribution of the proportion of 
individuals who are HIV positive among the entire adult 
population (men aged 15–59 and women aged 15–49). 
Pixel- level HIV prevalence for men ranged from 1.4% 
to 24.2% per 5 km2, with a median of 11.5% per 5 km2, 
and from 2.1% to 48.1% per 5 km2, with a median of 
20.6% per 5 km2 for women. The spatial structure of HIV 
prevalence showed some differences between the distri-
bution of the disease for men and women. HIV preva-
lence for women was higher in the north- eastern part of 
the country, particularly in Limpopo province, and in the 
south- eastern areas along with the coastline in KwaZulu- 
Natal and Eastern Cape provinces. Conversely, HIV preva-
lence for men was more concentrated in the mid- eastern 
part of the country among the Gauteng and KwaZulu- 
Natal provinces.
Figure 2C,D illustrates the geographical distribution of 
the estimated number of men living with HIV and women 
living with HIV, respectively. Using the spatial maps, we 
estimated a total of 3 367 810 men living with HIV aged 
15–59 and 3 861 228 women living with HIV aged 15–49 
in 2016 in South Africa. The highest density of PLHIV 
for both genders shows in Gauteng, and the lowest density 
Figure 3 People living with HIV (PLHIV) within underserved areas (30, 60 and 120 min thresholds) in South Africa. Estimated 
men living with HIV within 30 min threshold (A), 60 min threshold (B), and 120 min threshold (C) underserved areas; estimated 
women living with HIV within 30 min threshold (D), 60 min threshold (E), and 120 min threshold (F) underserved areas. Maps 
were created using ArcGIS by ESRI V.10.5 (http://www.esri.com).
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shows in Northern Cape. The density of PLHIV ranged 
from 0 per 5 km2 in Northern Cape for both genders to a 
maximum of 13 862 per 5 km2 for women and 15 484 per 
5 km2 for men in Gauteng. Specifically, men living with 
HIV concentrate in the urban areas, whereas women 
living with HIV were distributed both in urban and the 
periphery areas, covering the north- eastern and south- 
eastern parts of the country.
PLHIV within underserved areas
Figure 3A,D illustrates the population density of men 
living with HIV and women living with HIV within the 
underserved areas with 30 min threshold, respectively. 
The underserved areas based on 30 min travel time from 
the nearest healthcare facility across the country covered 
about 80% of the total territory (≈991 000 km2). About 
16.6% (≈559 581) of men living with HIV aged 15–59 
lived outside of a 30 min minimum travel time from the 
nearest hospital, whereas 20.4% (≈787 022) of women 
living with HIV aged 15–49 lived in those underserved 
areas, with a similar spatial pattern of PLHIV within the 
underserved areas for both genders. Most part of Gauteng 
province and coastal areas in KwaZulu- Natal province 
including the city of Durban were areas where health-
care services can be reached within 30 min. Likewise, 
figure 3B,E shows the population density of men living 
with HIV and women living with HIV within the under-
served areas with 60 min threshold, respectively. These 
underserved areas covered 62.1% of the total territory 
of the country, and 6.4% (≈216 419) of men living with 
HIV were located outside of the 60 min travel time to the 
nearest hospital threshold, whereas 7.9% (≈305 074) of 
women living with HIV lived in those underserved areas. 
Lastly, 37.1% of the total area of the country was located 
outside of a 120 min threshold from the nearest health-
care facility (figure 3C,F), and 1.6% (≈53 737) of men 
living with HIV lived outside of a 120 min travel time to 
the nearest hospital, whereas 1.9% (≈73 144) of women 
living with HIV were located in these underserved areas.
Table 2 summarises the estimated number and 
percentage of PLHIV within the underserved areas by 
province. Around 80% of PLHIV were living in five prov-
inces, including Gauteng, KwaZulu- Natal, Eastern Cape, 
Limpopo and Mpumalanga. Moreover, 50% of the PLHIV 
were located in Gauteng and KwaZulu- Natal provinces 
(46.66% for women living with HIV and 51.27% for men 
living with HIV). Although North West province contained 
a lower percentage of PLHIV (7.65% for women living 
with HIV and 7.58% for men living with HIV of the total 
PLHIV in the country), this province had the highest 
proportion of PLHIV within underserved areas with 
Table 2 The estimated number of PLHIV living in the underserved areas, and the number of health facilities per 1000 PLHIV 
















  Eastern Cape 495 547 (12.83) 133 628 (16.98) 39 720 (13.02) 8285 (11.33) 1.83
  Free state 189 708 (4.91) 45 899 (5.83) 26 297 (8.62) 4040 (5.52) 1.48
  Gauteng 1 004 439 (26.01) 42 783 (5.44) 8479 (2.78) 0 (0.00) 0.45
  KwaZulu- Natal 797 416 (20.65) 174 543 (22.18) 60 188 (19.73) 7593 (10.38) 0.93
  Limpopo 431 823 (11.18) 133 555 (16.97) 58 690 (19.24) 24 100 (32.95) 1.24
  Mpumalanga 376 178 (9.74) 126 764 (16.11) 57 593 (18.88) 12 456 (17.03) 0.94
  North West 295 370 (7.65) 75 913 (9.65) 31 200 (10.23) 4175 (5.71) 1.21
  Northern Cape 50 903 (1.32) 12 502 (1.59) 10 471 (3.43) 7097 (9.70) 4.58
  Western Cape 219 776 (5.69) 14 429 (1.83) 12 430 (4.07) 5393 (7.37) 2.01
Men
  Eastern Cape 328 618 (9.76) 77 660 (13.89) 24 537 (11.34) 5872 (10.93) 2.76
  Free state 181 787 (5.40) 34 339 (6.14) 19 569 (9.04) 3130 (5.83) 1.54
  Gauteng 972 130 (28.87) 28 689 (5.13) 5499 (2.54) 0 (0.00) 0.47
  KwaZulu- Natal 754 290 (22.40) 149 197 (26.68) 49 547 (22.90) 5948 (11.07) 0.99
  Limpopo 250 860 (7.45) 69 400 (12.41) 29 579 (13.67) 12 125 (22.57) 2.13
  Mpumalanga 290 587 (8.63) 89 993 (16.09) 41 027 (18.96) 9659 (17.98) 1.21
  North West 255 133 (7.58) 56 360 (10.08) 22 196 (10.26) 2811 (5.23) 1.40
  Northern Cape 65 048 (1.93) 14 327 (2.56) 12 182 (5.63) 8604 (16.01) 3.58
  Western Cape 268 245 (7.97) 39 181 (7.01) 12 266 (5.67) 5578 (10.38) 1.65
PLHIV, people living with HIV.
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30 and 60 min thresholds. Moreover, Gauteng prov-
ince contained the largest proportion of PLHIV of the 
country for both genders, 26.01% for women living with 
HIV and 28.87% for men living with HIV. This province 
showed low number of PLHIV located within the under-
served areas, with less than 5% of PLHIV in the under-
served areas with 120 min threshold, and also had the 
lowest numbers of healthcare facilities per 1000 PLHIV 
among all provinces (0.45 for women living with HIV and 
0.47 for men living with HIV). Conversely, Northern Cape 
and Western Cape provinces showed the lowest percentage 
of PLHIV of the entire country (1.32% and 5.69% for 
women living with HIV, and 1.93% and 7.97% for men 
living with HIV, respectively) and the highest numbers 
of healthcare facilities per 1000 PLHIV (4.58 and 2.01 
for women living with HIV, and 3.58 and 1.65 for men 
living with HIV, respectively). However, these provinces 
contained a large number of PLHIV within underserved 
areas with 120 min threshold (9.70% and 7.37% for 
women living with HIV and 16.01% and 10.38% for men 
living with HIV).
DISCUSSION
HIV prevalence for both men and women showed 
remarkable geographical variation in South Africa, 
with the burden of infection concentrated in the 
eastern part of the country, among the provinces of 
Gauteng, KwaZulu- Natal, Eastern Cape, Limpopo and 
Mpumalanga, and with high concentration of PLHIV 
identified near urban settings of the eastern part of 
the country, including Johannesburg and Durban. 
For example, Gauteng shows the highest percentage 
of the average HIV prevalence for women, with 30.6% 
per 5 km2 and ranges from 18% to a maximum of 42% 
per 5 km2. For men, the average HIV prevalence in 
Gauteng shows 14.7% per 5 km2 and ranges from 8% 
to a maximum of 24% per 5 km2. We identified gender 
differences in the distribution of the HIV epidemic, 
with the HIV prevalence for women more concen-
trated in the northern- eastern and southern- eastern 
parts of the country compared with the concentration 
of men in the eastern part of South Africa. Moreover, 
PLHIV who are unlikely to access healthcare services 
within at least a 60 min time threshold are located 
in eastern part of the country among the Limpopo 
and KwaZulu- Natal provinces, and a large number of 
PLHIV near Kruger National Park across Limpopo and 
Mpumalanga, in the vicinity villages of Phalaborwa 
and Shangaan, near Hazyview town, are unlikely to 
access health services within a 120 min travel time.
Our results suggest that variables such as MC and 
poverty are key drivers of the spatial variation of HIV 
prevalence in South Africa. MC showed a significant 
association with the spatial structure of HIV for men. 
With the effectiveness of MC to reduce HIV infections 
among men,32 the South Africa government imple-
mented the 2012–2016 National Strategic Plan (NSP) 
to circumcise 80% of HIV- negative men aged 15–49 
by 2015 (SANAC, 2011).33 As a result, South Africa 
achieved a significant increase of MC from 25% in 
2013 to 57% in 2016, but with marked spatial vari-
ation among provinces, with 35% MC prevalence in 
Northern Cape compared with 86% in Limpopo.21 The 
government launched the NSP 2017–2022 with a 
new target of 3 million circumcised men by 2021.34 
Besides the direct impact of MC on the reduction of 
HIV acquisition, MC could also generate secondary 
benefits by affecting the sexual behaviour of circum-
cised men.35 For example, circumcised men tend to 
be concerned more about partner’s HIV status and 
to use condoms more frequently compared with non- 
circumcised men in South Africa.35 Likewise, poverty 
was also a significant explanatory variable associated 
with the spatial structure of HIV for both men and 
women. This result is consistent with a previous study 
showing that poorer women are more likely to have 
burden of HIV infection and have engaged in risky 
sexual behaviour especially for young women, such 
as earlier sexual debut, having had multiple sexual 
partners in the year, lower chance of condom use and 
having traded sex, compared with women in more 
affluent households.36 37 For both genders, poverty 
reduces the chance of discussing safe- sex practices 
with their partner.36
According to the UNAIDS Global Report in 2019, 
South Africa is one of the countries showing the great 
decline in new HIV infections with more than 50% 
of reduction in AIDS- related deaths between 2010 
and 2018.1 The South Africa government launched 
a series of strategic plans as a response to HIV and 
updated the NSP four times (2000–2005, 2007–2011, 
2012–2016, 2017–2022) to expand the coverage of 
prevention and treatment guidelines towards the ulti-
mate goal of the elimination of HIV by 2030. South 
Africa has also increased domestic funds for HIV by 
about $650 million between 2010 and 2018, and now 
78% of the total HIV funding resources in the country 
are domestic.1 Despite these efforts, South Africa has 
a 19.1% HIV prevalence among the adult population 
aged 15–49 years.1 One of the approaches included 
in the NSP 2017–2022 is the identification of priority 
areas and key vulnerable populations as a strategy 
for optimal resource allocation, and to build an envi-
ronment that maximises coverage of HIV prevention 
and treatment services. As discussed previously, since 
spatial distance from residence to healthcare facilities 
for PLHIV is a major barrier to receiving adequate 
healthcare, allocating resources and controlling HIV 
prevention and treatment services are critical strate-
gies to overcome the spatial barrier. Here, we local-
ised HIV- underserved areas that could hinder South 
Africa in meeting UNAIDS targets and identified 
areas in need of appropriate HIV prevention and 
treatment services. Our analysis identified the areas 
where the travel time takes more than 30, 60 and 120 
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min to the nearest healthcare facility and indicated 
that more than 550 000 men living with HIV (17% 
among the total men living with HIV) and 750 000 
women living with HIV (20% among the total women 
living with HIV) are living in areas where travel time 
to the nearest facility took at least 30 min.
The highest density of PLHIV in South Africa was 
concentrated in Gauteng province (around 1 million 
(26%) persons) with a maximum of 13 862 women per 
5 km2 and 15 484 men per 5 km2. Since the borders 
of this province covered a small area, the numbers of 
PLHIV living in underserved areas rapidly decreased 
to zero. However, our results suggest that this prov-
ince has the lowest number of healthcare facilities 
per 1000 PLHIV (0.45 for women and 0.47 for men), 
and although this province is characterised by easy- to- 
access health services with a short travel time, the abso-
lute number of healthcare facilities may not satisfy the 
demand generated by the large numbers of PLHIV 
who need HIV treatment. Moreover, according to a 
recent analysis, Gauteng showed the slowest progress 
towards the 90-90-90 targets between 2003 and 2015 
due to budget allocation.38 Gauteng and Mpumalanga 
had the lowest amount of HIV expenditure per HIV- 
positive individuals whereas Northern Cape and Free 
State had the highest amount of HIV expenditure.38
KwaZulu- Natal province had the second largest 
numbers of PLHIV for men and women (more than 700 
000 PLHIV; 21%) with more than 10% of these PLHIV 
living in underserved areas. Similar to Gauteng, the 
province had lower numbers of healthcare facilities per 
1000 PLHIV (0.99 for men and 0.93 for women). With 
the NSP 2017–2022 for HIV, the province implemented 
the Provincial Growth and Development Strategy 2035 
along with the 90-90-90 strategy and set a new goal to 
eliminate HIV infections by 2035.39 As a result, the prov-
ince achieved a significant decline of HIV infection by 
27% between 2012 and 2016.39 The province classified 
districts into three categories (ie, high triple burden of 
HIV, tuberculosis (TB) and sexually transmitted infec-
tions (STI); dual high burden of HIV; high- burden 
districts of STI) to efficiently treat districts with limited 
resources and expenditure based on importance towards 
eliminating of HIV, TB and STI.39 According to the 
KwaZulu- Natal Provincial Multi- Sectoral HIV, TB and STI 
Implementation Plan 2017–2022, acceleration, intensi-
fication, inclusivity, participation and efficiency in the 
provision of services will be hallmark of the interventions 
and activities of this plan, given the dire situation of the 
epidemics in KwaZulu- Natal and for the fact that it is 
considered the epicentre of the epidemic in the country. 
Towards this end, the province adopted the ‘Focus for 
Impact’ methodology to assist localities with the greatest 
burden to targeting these settings with interventions and 
activities. The essence of the methodology is to deliver 
results that can provide the greatest impact with limited 
resources and highest value for money. Results have 
shown that five of the province’s 11 districts, namely (1) 
eThekwini; (2) iLembe; (3) uThukela; (4) uMgungundlovu; 
and (5) Ugu, have a high triple burden of HIV, TB and 
STIs. Four of the 11 districts have a dual high burden 
as follows: (1) King Cetshwayo and (2) Zululand (high 
burden of HIV and TB), (3) Harry Gwala (high HIV and 
STI burden), and (4) uMkhanyakude (high TB and STI 
burden). Amajuba, on the other hand, has a high STI 
burden.39 As the priority group, the high triple burden 
of HIV districts, including eThekwini, iLembe, uThukela, 
uMgungundlovu and Ugu, is located in the southern part 
of the province near the city of Durban.39 The results of 
our analysis show similar spatial patterns with this policy 
in terms of PLHIV. However, we found that the areas with 
higher needs of HIV prevention and treatment services 
are located in the northern part of the province, which is 
classified as a dual high- burden district since the districts 
contain a large number of PLHIV who are not likely to 
access the nearest health facility within a certain travel 
time.
Lastly, areas near Kruger National Park in Limpopo 
and Mpumalanga provinces had the largest number 
of PLHIV who needed at least 120 min to access the 
nearest healthcare facility. Limpopo and Mpumalanga 
provinces implemented the provincial strategic plan 
2012–2016 with goals based on the NSP 2017–2022.40 41 
However, since the two provinces are exposed to truck 
routes across borders with Zimbabwe, Mozambique 
and Zambia, these areas could be exposed to high 
movement of population that might increase the risk 
of HIV, and thus the intensification programmes for 
accessible HIV prevention and treatment for PLHIV 
within the areas might need to be implemented.40 41
We identified spatial variations of HIV prevalence 
and PLHIV at a high- resolution level for both genders 
and discovered underserved areas that healthcare 
services cannot reach at the high- resolution level. 
However, several study limitations could have affected 
our results. First, some of the variables included in 
the study could have been affected by inherent biases 
in the data due to the multiple logistical difficulties 
in conducting SADHS, such as variability in response 
rates to HIV testing. SADHS was conducted based on 
individuals who were interviewed and participated in 
HIV testing. The sample weighting procedures were 
applied to correct for differential non- responses, 
considering provincial characteristics, residential 
place and gender. However, the generalisability of the 
prevalence estimates can be unclear.42 43 For example, 
some high- risk subpopulations, such as women sex 
workers, injection drug users, men who have sex 
with men and mobile individuals, could have been 
missed.12 Since South Africa shares borders with other 
countries including Mozambique, Zambia, Namibia, 
Eswatini and Lesotho, migration and mobile popu-
lations could affect our findings. The methodology 
used to calculate HIV prevalence and PLHIV is not 
able to capture temporal changes due to migration, 
and the sources of data did not include information 
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regarding mobile individuals which could affect esti-
mations near the country borders.12 Moreover, MC 
prevalence was estimated from self- reported status of 
circumcision, and thus does not discriminate among 
different types of MC like traditional or medical 
circumcision. However, since our analysis focused on 
the general relationship between circumcised men 
and the spatial structure of HIV prevalence, we expect 
that this generalisation does not affect the main find-
ings of our study.44 45 Lastly, the displacement process 
of the SADHS sampling data point via global posi-
tioning system might cause potential spatial bias.12 
This process could have an impact on the precision of 
the continuous surface of HIV prevalence and PLHIV 
by a few kilometres.
CONCLUSION
Although South Africa achieved the first of the 
UNAIDS 90-90-90 targets, a large number of PLHIV 
are still in need for treatment, and precise geographic 
targeting of HIV prevention and treatment services 
might facilitate the country to meet the second of 
the UNAIDS 90-90-90 targets. Using spatial epidemi-
ological approaches to investigate HIV prevalence 
and underserved areas from healthcare facilities, we 
identified more than 1 million of PLHIV in areas with 
the lack of access to healthcare within 30 min travel 
time. These findings can shed light on areas that have 
been aggregated in the province or national levels to 
represent HIV prevalence to support a cost- effective 
decision process for decision makers by geographi-
cally targeting certain areas. Therefore, special atten-
tion should be given to the development and imple-
mentation of tailored HIV prevention and treatment 
programme, especially in areas identified as under-
served areas for PLHIV. The statistical modelling and 
high- resolution maps of HIV prevalence and PLHIV 
provide valuable information to support decision- 
making process to achieve the national and interna-
tional goals for the elimination of HIV by increasing 
the effective HIV prevention and treatment services 
in those areas with the greatest need.
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